🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Proud of Damie Odufalu for🎹work on steroid risk in preg IBD. Steroids assoc. w/ ⬆️PTB, LBW, NICU. ⬆️infxn w/ T2,T3 use ⬆️birth defect w/ T1 use. Dx activity of course plays a role. Optimize remission prior to pregnancy when possible! Millie Long Gut Journal gut.bmj.com/content/early/…

Phenomenal work on vaccine response to #COVID19 vaccines for #IBD patients by superstar Valeriya Pozdnyakova #CORALEIBD IBD at Cedars-Sinai Presidential poster winner! Gil Y. Melmed, MD, MS Dr Dermot McGovern @GJBotwin Stephan Targan ACG

A very big thank you to Gil Y. Melmed, MD, MS and all the PIs IBD at Cedars-Sinai & CORALE study team for making this happen and giving us the opportunity to contribute to science during this historical moment!! Dr Dermot McGovern ACG #2021ACG #CORALEIBD

The long lists of foods to avoid generated by these food sensitivity tests prime patients for over- restriction, food related anxiety, and malnutrition.

The US Multi-Society Task Force on CRC, comprised of representatives from American Gastroenterological Association (AGA) ACG & ASGE GI Endoscopy released updated screening recommendations, endorsing 45 as the age to start average-risk screening. Published in Gastroenterology ow.ly/B8CL50GNPQ0

MGH (with the help of Helmsley trust) is launching a new international study of Crohn's disease among South Asians and changes that happen with immigration. We welcome collaboration and assistance with recruitment on this important topic! Thanks for the interest!

Symptoms after mRNA #CovidVaccine booster are generally milder and less frequent than after 2nd dose in those with #IBD. CORALE-IBD preprint for those with #Crohns and #ulcerativecolitis is reassuring! Dr Dermot McGovern Dalin Li medrxiv.org/content/10.110…

Important read for IBD 2021: AGA Guidelines for Crohn's DX🔥 Guideline: gastrojournal.org/action/showPdf… Tech Rev: gastrojournal.org/action/showPdf… Spotlight: gastrojournal.org/action/showPdf… Commentary: gastrojournal.org/action/showPdf… 🙏American Gastroenterological Association (AGA) Gastroenterology for giving me the honor to work on this.

4. Approach to management of recently diagnosed #IBD patients #Top10 #IBD #GItwitter #MondayNightIBD ncbi.nlm.nih.gov/pmc/articles/P…

📝IMPORTANT ACG Survey Findings! New data gathered from ACG members on their #PriorAuthorization experience reveal #PriorAuth is ☑️Detrimental to patient care ☑️Overwhelming #Gastroenterology practices ☑️Harming patients Data: bit.ly/ACG-Prior-Auth… #FixPriorAuth #GItwitter

“Female PCPs receive 24% more staff messages (9.6 messages/month), and 26% more patient messages (51.5 messages/month) than their male counterparts.” 🤯🤯🤯 What do we do about this? #medtwitter pubmed.ncbi.nlm.nih.gov/34993875/

Ready, set…go! 🎖 🔷Get out your🏃🏿‍♀️shoes or 🚴 for March! 🔷March is #ColorectalCancerAwarenessMonth! 🔷Join myself & ACG colleagues as we #RideOrStrideFor45. 🔷Register now 🖥 🔷Get swag🏅 🔷Show us what you got! 👊🏼 #45TheNew50 bit.ly/ACGRideOrStrid…

Happy National #ColorectalCancerAwarenessMonth! Here's our plan this month: ❗ Raise awareness - screening saves lives & should now start at age 45 🎉 Celebrate the GIs who dedicate their lives to preventing #coloncancer 🤝 Provide resources to support GIs & their patients

Upadacitinib (Rinvoq), a tablet approved today for ulcerative colitis, appears to be more effective than all existing therapies for UC #IBD in a network meta-analysis (not head to head trials yet) gut.bmj.com/content/early/…

‼️ NEW ACG CAG Joint ACG-CAG Guidelines on Management of Anticoagulants & Antiplatelets during Acute GI Bleeding & Periendoscopic Period Neena S Abraham MD MACG FASGE AGAF Grigoris Leontiadis @Alan_barkun Loren Laine Bryan Sauer MD MSc #JenTelford #CardioGI 📕bit.ly/ACG-CAG-Abraha…

⁦Maria T. Abreu: “we have seen the enemy, and it is ourselves.” 40% of female physicians did not take maternity leave. 😳

Head to head studies in IBD - 🧵

(1/13)📢 New med option for mod to severe Crohn's disease: Risankizumab-rzaa (Skyrizi) - IL23 antagonist 🏥 Induction: 600 mg IV @ wk 0, 4, 8 (1 hour) 💉Maintenance: 360 mg @ wk 12, then q8 weeks [single-dose prefilled cartridge] ☑️ EIM: psoriatic arthritis, plaque psoriasis

Patients with inflammatory bowel disease (IBD) experience fewer and milder SARS-CoV-2 mRNA postvaccination symptoms, compared with individuals without IBD. Angela Mujukian, MD Rashmi Kumar Dr Dermot McGovern Gil Y. Melmed, MD, MS #GItwitter #gastroenterology brnw.ch/21wCGSs

🚨🚨Excellent review on imaging in IBD including #intestinalultrasound by Rashmi Kumar! Gil Melmed @GIDrHwang InternationalBowelUS IBD at Cedars-Sinai authors.elsevier.com/a/1jft-,KEwQU1…